Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions:   Overweight;   Obesity Intervention:   Other: Source document data collection Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions:   Overweight;   Obesity Interventions:   Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg;   Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg;   Drug: SIB Group Sibus (Sibutramine) 15mg;   Drug: Placebo Group Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions:   Overweight;   Obesity Intervention:   Other: Source document data collection Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions:   Overweight;   Obesity Interventions:   Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg;   Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg;   Drug: SIB Group Sibus (Sibutramine) 15mg;   Drug: Placebo Group Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions:   Overweight;   Obesity Intervention:   Other: Source document data collection Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions:   Overweight;   Obesity Interventions:   Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg;   Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg;   Drug: SIB Group Sibus (Sibutramine) 15mg;   Drug: Placebo Group Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions:   Overweight;   Obesity Intervention:   Other: Source document data collection Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions:   Overweight;   Obesity Interventions:   Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg;   Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg;   Drug: SIB Group Sibus (Sibutramine) 15mg;   Drug: Placebo Group Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions:   Overweight;   Obesity Intervention:   Other: Source document data collection Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions:   Overweight;   Obesity Interventions:   Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg;   Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg;   Drug: SIB Group Sibus (Sibutramine) 15mg;   Drug: Placebo Group Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions:   Overweight;   Obesity Intervention:   Other: Source document data collection Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions:   Overweight;   Obesity Interventions:   Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg;   Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg;   Drug: SIB Group Sibus (Sibutramine) 15mg;   Drug: Placebo Group Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions:   Overweight;   Obesity Intervention:   Other: Source document data collection Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials